NEW PRODUCT LAUNCH ANNOUNCEMENT: Sitagliptin/IASIS 25 mg/mL oral solution
An Innovative, Important & Unique Prescribing Option for Improving Glycemic Control in Type 2 Diabetes Mellitus IASIS PHARMA is pleased to announce the launch of Sitagliptin/IASIS 25 mg/mL in the pharmaceutical form of an oral solution. This is a new, innovative, and unique formulation belonging to the class of DPP-4i. It is an R&D and [...]


